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LETTERS TO THE EDITORRegarding “Race as a predictor of morbidity, mortality,
and neurologic events after carotid endarterectomy”
Brown et al1 raised an important issue on racial inequality.
Although the authors are correct that racial differences may exist
among patients with carotid stenosis, it is less certain that race
can be a predictor of morbidity and mortality after carotid endar-
terectomy (CEA).
We would like to elaborate on the limitations of the study.
The study was limited to hospitals that participated in American
College of Surgeons National Surgical Quality Improvement
Program (ACS-NSQIP), which leads to a selection bias for the
study cohort. ACS-NSQIP is a nationally validated, risk-adjusted,
outcome-based quality improvement program that measures and
improves surgical care.2 Although hospital information is deiden-
tifed in the database, one can conclude that participating hospitals
have considerable resources dedicated to quality improvement.
Therefore, complication rates might be lower in ACS-NSQIP
hospitals compared with all of the hospitals in the United States.
Moreover, ACS-NSQIP is limited to hospitals in the private sector.
Veterans Affairs hospitals and other federal and state hospitals are
not included in the program. The proportion of black patients
might be higher if data from these hospitals were included.
When complication rates or the proportion of black patients are
higher, the racial difference might not be as evident.
In addition, the study cohort was limited to CEAs performed
by vascular surgeons. Even though vascular surgeons perform most
of the CEAs, other specialists (5% in 2007-2009 ACS-NSQIP)
continue to treat carotid stenosis.3 Hollenbeak et al4 found that
stroke rates were lower if CEA was performed by vascular surgeons
compared with others; therefore, limiting the results to vascular
surgeons can potentially alter the results.
The authors pointed out the most important limitations of the
study: “variables speciﬁc to carotid interventions”were not included
in the ACS-NSQIP.1 Oddone et al5 found that black patients were
more likely to present with stroke and less likely to be taking antipla-
telet or anticoagulation therapy than white patients. The current
study would have been more convincing if the results had been
correlated with acute presenting signs and symptoms and prior
medical treatment. Although the authors included prior stroke in
the multivariate analysis, prior stroke in ACS-NSQIP can occur at
any point in the patient’s history. When symptoms were included,
the risk ratio for symptoms was much higher than in black race
for postoperative stroke and mortality.6 Therefore, one cannot
conclude from the results of the current study that the higher
morbidity and mortality observed in black patients were due to
race, disease etiology, or delay in appropriate care.
Future research examining possible racial differences in vascular
procedures should consider the following factors:The analysis should
represent all types of hospitals and specialists that treat vascular
patients. Instead of focusing on the effect of race on postoperative
complications, the focus should be on how patients are presented
at the time of surgery. If the percentage of black patients receiving
appropriate medical therapy increases, the percentage of symptom-
atic black patients will likely be decreased, and the rate of postopera-
tive complications will likely be reduced. The medical and surgical
community should focus on these issues of access to care.
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Reply
We thank Ju and Kibbe for their response to our article “Race
as a predictor of morbidity, mortality, and neurologic events after
carotid endarterectomy.”
Although we acknowledge the limitations of the NSQIP
database and the potential considerable resources of hospitals
within this database, we do note that the conclusions from
our study have been suggested by other authors who looked
at the Medicare database1 and the Maryland Health Services
Database.2 These databases likely have additional and different
demographics than the National Surgical Quality Improvement
Program and have suggested similar epidemiology in their
ﬁndings.
We limited our evaluation to vascular surgeons because, as you
have acknowledged, vascular surgeons perform most of the carotid
endarterectomies. By standardizing the surgeon performing the
operation, we sought to remove this factor as a potential con-
founding variable in outcomes.
We do agree that the current study would have been enhanced
if the results could have been correlated with acute presenting signs
and symptoms and prior medical treatment; however, these data
are just not available in such a database.
We do agree that future research examining possible racial
differences in vascular procedures should be as inclusive as
